Cargando…
Psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis
OBJECTIVES: Our aim was to identify the impact of psychosocial predictors, specifically relationship style, depressive symptoms, anxiety symptoms, cognitive impairment, and culture-specific disease beliefs, on treatment adherence for multiple sclerosis (MS) patients. METHODS: In this cross-sectional...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352251/ https://www.ncbi.nlm.nih.gov/pubmed/28331298 http://dx.doi.org/10.2147/PPA.S129678 |
_version_ | 1782514920700510208 |
---|---|
author | Alosaimi, Fahad D AlMulhem, Alaa AlShalan, Hanan Alqazlan, Mohammad Aldaif, Abdulgader Kowgier, Matthew Balasundaram, Janooshsheya Sockalingam, Sanjeev |
author_facet | Alosaimi, Fahad D AlMulhem, Alaa AlShalan, Hanan Alqazlan, Mohammad Aldaif, Abdulgader Kowgier, Matthew Balasundaram, Janooshsheya Sockalingam, Sanjeev |
author_sort | Alosaimi, Fahad D |
collection | PubMed |
description | OBJECTIVES: Our aim was to identify the impact of psychosocial predictors, specifically relationship style, depressive symptoms, anxiety symptoms, cognitive impairment, and culture-specific disease beliefs, on treatment adherence for multiple sclerosis (MS) patients. METHODS: In this cross-sectional observational study, patients from two MS clinics in Saudi Arabia completed self-reported questionnaires focused on MS treatment adherence, physical symptom burden, relationship style, cultural beliefs, depressive symptoms, anxiety, and cognitive impairment. RESULTS: A total of 163 MS patients participated, 81.6% of them were female, and the mean age of the patients was 31.6 years. Mean patient-reported adherence to their MS treatment regimen was 79.47%±25.26%. Multivariate linear regression analysis only identified patients’ belief that their MS was due to “supernatural” forces as being significantly negatively associated with MS medication adherence. CONCLUSION: This study demonstrates the importance of cultural interpretations to MS medication adherence in comparison to psychosocial factors. Education and family involvement in the treatment planning may address this issue and warrant further research. |
format | Online Article Text |
id | pubmed-5352251 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-53522512017-03-22 Psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis Alosaimi, Fahad D AlMulhem, Alaa AlShalan, Hanan Alqazlan, Mohammad Aldaif, Abdulgader Kowgier, Matthew Balasundaram, Janooshsheya Sockalingam, Sanjeev Patient Prefer Adherence Original Research OBJECTIVES: Our aim was to identify the impact of psychosocial predictors, specifically relationship style, depressive symptoms, anxiety symptoms, cognitive impairment, and culture-specific disease beliefs, on treatment adherence for multiple sclerosis (MS) patients. METHODS: In this cross-sectional observational study, patients from two MS clinics in Saudi Arabia completed self-reported questionnaires focused on MS treatment adherence, physical symptom burden, relationship style, cultural beliefs, depressive symptoms, anxiety, and cognitive impairment. RESULTS: A total of 163 MS patients participated, 81.6% of them were female, and the mean age of the patients was 31.6 years. Mean patient-reported adherence to their MS treatment regimen was 79.47%±25.26%. Multivariate linear regression analysis only identified patients’ belief that their MS was due to “supernatural” forces as being significantly negatively associated with MS medication adherence. CONCLUSION: This study demonstrates the importance of cultural interpretations to MS medication adherence in comparison to psychosocial factors. Education and family involvement in the treatment planning may address this issue and warrant further research. Dove Medical Press 2017-03-09 /pmc/articles/PMC5352251/ /pubmed/28331298 http://dx.doi.org/10.2147/PPA.S129678 Text en © 2017 Alosaimi et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Alosaimi, Fahad D AlMulhem, Alaa AlShalan, Hanan Alqazlan, Mohammad Aldaif, Abdulgader Kowgier, Matthew Balasundaram, Janooshsheya Sockalingam, Sanjeev Psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis |
title | Psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis |
title_full | Psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis |
title_fullStr | Psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis |
title_full_unstemmed | Psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis |
title_short | Psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis |
title_sort | psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352251/ https://www.ncbi.nlm.nih.gov/pubmed/28331298 http://dx.doi.org/10.2147/PPA.S129678 |
work_keys_str_mv | AT alosaimifahadd psychosocialpredictorsofpatientadherencetodiseasemodifyingtherapiesformultiplesclerosis AT almulhemalaa psychosocialpredictorsofpatientadherencetodiseasemodifyingtherapiesformultiplesclerosis AT alshalanhanan psychosocialpredictorsofpatientadherencetodiseasemodifyingtherapiesformultiplesclerosis AT alqazlanmohammad psychosocialpredictorsofpatientadherencetodiseasemodifyingtherapiesformultiplesclerosis AT aldaifabdulgader psychosocialpredictorsofpatientadherencetodiseasemodifyingtherapiesformultiplesclerosis AT kowgiermatthew psychosocialpredictorsofpatientadherencetodiseasemodifyingtherapiesformultiplesclerosis AT balasundaramjanooshsheya psychosocialpredictorsofpatientadherencetodiseasemodifyingtherapiesformultiplesclerosis AT sockalingamsanjeev psychosocialpredictorsofpatientadherencetodiseasemodifyingtherapiesformultiplesclerosis |